Cheah Chen Seh (Cheah C Seh)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Hematopoietic Stem Cell

Top Venues

Cancer immunology research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Pei Yun Teo, Youngrock Jung, David H Quach, Joanna Koh, Richard Weijie Ong, Angeline Xh Goh, Alrina Shin Min Tan, Chee Hoe Ng, Cheah Chen Seh, Kar Wai Tan, Ivan D Horak, Lionel Low
Overexpression of an Engineered SerpinB9 Enhances Allogeneic T-Cell Persistence and Efficacy. Cancer immunology research (2024)
Pei Yun Teo, Youngrock Jung, David H Quach, Joanna Koh, Richard Weijie Ong, Angeline Xh Goh, Alrina Shin Min Tan, Chee Hoe Ng, Cheah Chen Seh, Kar Wai Tan, Ivan D Horak, Lionel Low
Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy. Cancer immunology research 12 (8) (2024)
Stephanie A Moquin, Oliver Simon, Ratna Karuna, Suresh B Lakshminarayana, Fumiaki Yokokawa, Feng Wang, Chandra Saravanan, Jin Zhang, Craig W Day, Katherine Chan, Qing-Yin Wang, Siyan Lu, Hongping Dong, Kah Fei Wan, Siew Pheng Lim, Wei Liu, Cheah Chen Seh, Yen-Liang Chen, Haoying Xu, David T Barkan, Cyrille S Kounde, Wei Lin Sandra Sim, Gang Wang, Hui-Quan Yeo, Bin Zou, Wai Ling Chan, Mei Ding, Jae-Geun Song, Min Li, Colin Osborne, Francesca Blasco, Christopher Sarko, David Beer, Ghislain M C Bonamy, Vito G Sasseville, Pei-Yong Shi, Thierry Tidiane Diagana, Bryan K S Yeung, Feng Gu
NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models. Science translational medicine 13 (579) (2021)